RPN2 and cancer: In addition to its role in N-linked glycosylation, ribophorin II is an important molecular marker in various cancers and has been associated with drug resistance in solid cancers (Honma et al., 2008; Kurashige et al., 2012; Fujita et al., 2015; Yuan et al., 2015).